MD Anderson Cancer Center
Stereotactic body radiation therapy cancer treatment – CNL
Stereotactic body radiation therapy (SBRT) differs from traditional radiation therapy for cancer patients. Treatment takes less time (four days versus seven weeks), it’s double the radiation dose and it spares the healthy tissue surrounding the tumor. SBRT is commonly used to treat lung and pancreatic cancers, as well as cancers that have spread to the liver, lung, adrenal glands and spine. Joe Chang, M.D., Ph.D., associate professor in Radiation Oncology at MD Anderson Cancer Center, explains why this treatment may be best option for some cancer patients, and gives reasons why MD Anderson is the leader in SBRT treatment.

Transcript Transcript     Accessibility shortcut keys (H) Shortcuts
Loading the Audio Player...

Title: Stereotactic body radiation therapy cancer treatment – CNL
Summary: Stereotactic body radiation therapy (SBRT) differs from traditional radiation therapy for cancer patients. Treatment takes less time (four days versus seven weeks), it’s double the radiation dose and it spares the healthy tissue surrounding the tumor. SBRT is commonly used to treat lung and pancreatic cancers, as well as cancers that have spread to the liver, lung, adrenal glands and spine. Joe Chang, M.D., Ph.D., associate professor in Radiation Oncology at MD Anderson Cancer Center, explains why this treatment may be best option for some cancer patients, and gives reasons why MD Anderson is the leader in SBRT treatment.
Keywords: cnl, cancer newsline, sbrt, Stereotactic body radiation therapy, treatment, cancer, radiation, lung, liver, pancreas, pancreatic, metastatic, metastases, spread, Adrenal glands, spine, joe chang, spread, computerized tomography, magnetic resonance imaging, positron emission tomography scanning, X-ray, imaging, ct scan
Transcript: http://www.mdanderson.org/transcripts/cancer-newsline/2012/stereotactic-body-radiation-therapy-cancer-treatment-6-18-12.htm